Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation

Purpose This study investigated the effect of the herbal medicine baicalin on bupropion hydroxylation, a probe reaction for CYP2B6 activity related to different CYP2B6 genotype groups. Method Seventeen healthy male volunteers (6 CYP2B6*1/*1, 6 CYP2B6*1/*6, and 5 CYP2B6*6/*6) received orally administ...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical pharmacology Vol. 65; no. 4; pp. 403 - 409
Main Authors Fan, Lan, Wang, Jin-Chao, Jiang, Feng, Tan, Zhi-Rong, Chen, Yao, Li, Qing, Zhang, Wei, Wang, Guo, Lei, He-Ping, Hu, Dong-Li, Wang, Dan, Zhou, Hong-Hao
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Berlin/Heidelberg : Springer-Verlag 01.04.2009
Springer-Verlag
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose This study investigated the effect of the herbal medicine baicalin on bupropion hydroxylation, a probe reaction for CYP2B6 activity related to different CYP2B6 genotype groups. Method Seventeen healthy male volunteers (6 CYP2B6*1/*1, 6 CYP2B6*1/*6, and 5 CYP2B6*6/*6) received orally administered bupropion alone and during daily treatment with baicalin. Blood samples were taken up to 72 h after each bupropion dose, and pharmacokinetics profiles were determined on days 1 and 25 for bupropion and hydroxybupropion. Result Baicalin administration increased hydroxybupropion maximum plasma concentration (C max) by 73% [90% confidence interval (CI), 44-108%; P < 0.01] and the area under the concentration time curve extrapolated to infinity (AUC₀₋[infinity]) of hydroxybupropion by 87% (90% CI, 48-137%; P < 0.01), with no change in the elimination half-life of hydroxybupropion. Baicalin increased the AUC₀₋[infinity] ratio of hydroxybupropion to bupropion by 63% (90% CI, 38-92%; P < 0.01). Conclusion Baicalin significantly induced CYP2B6-catalyzed bupropion hydroxylation, and the effects of baicalin on other CYP2B6 substrate drugs deserve further investigation.
Bibliography:http://dx.doi.org/10.1007/s00228-008-0594-3
ISSN:0031-6970
1432-1041
DOI:10.1007/s00228-008-0594-3